chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Body ache; had a fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (Body ache) and PYREXIA (had a fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body ache) and PYREXIA (had a fever). At the time of the report, MYALGIA (Body ache) and PYREXIA (had a fever) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided. The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Rash, Vaccination site reaction
Clinical narrative: COVID arm; Rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm) and RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (COVID arm) and RASH (Rash). At the time of the report, VACCINATION SITE REACTION (COVID arm) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant Medications were reported. No Treatment Information Provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore Throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore Throat) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (Sore Throat). At the time of the report, OROPHARYNGEAL PAIN (Sore Throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications are not provided. Treatment information does not provided.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced CHILLS (Chills). At the time of the report, CHILLS (Chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were reported. Treatment medication was not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Rash pruritic
Clinical narrative: itchy rash; pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain) and RASH PRURITIC (itchy rash) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no reported medical history). Concomitant products included PROBIOTICS NOS, IBUPROFEN, FISH OIL, TADALAFIL (CIALIS), VITAMIN D3, MULTIVITAMINS [VITAMINS NOS] and CYANOCOBALAMIN (VIT B12) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN (pain). On 03-Mar-2021, the patient experienced RASH PRURITIC (itchy rash). On 27-Feb-2021, PAIN (pain) had resolved. At the time of the report, RASH PRURITIC (itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information for the event included Steroid cream that didn't work and Benadryl lotion that seemed to helped.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza, Malaise, Nervousness
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of malaise (feeling off), nervousness (legs felt shaky), influenza-like illness (mild case of the flu), fatigue (exhaustion) and headache in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 024M20A) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Feb 18, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Feb 18, 2021, patient experienced malaise (feeling off), nervousness (legs felt shaky), influenza-like illness (mild case of the flu), fatigue (exhaustion), headache and fatigue (extreme fatigue). On Feb 25, 2021, malaise (feeling off), nervousness (legs felt shaky), influenza-like illness (mild case of the flu), fatigue (exhaustion), headache and fatigue (extreme fatigue) resolved. The action taken with mRNA-1273 (Moderna COVID-19  vaccine), intramuscular: unknown. The reporter did not provide any causality assessments. The consumer is later scheduled to receive the second dose of the Moderna COVID-19 vaccine on Mar 18, 2021. Concomitant medications not provided. Treatment information included Tylenol and Motrin (self medicating). Most recent follow-up information incorporated above included: On May 4, 2021: Non-significant follow-up (contact information updated).
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Dysphonia, Dyspnoea, Illness, Laryngitis
Clinical narrative: problem breathing; problem swallowing; upward pressure on the base of throat and under sternum "like a fist"; laryngitis-type state; severe hoarseness; throat real sensitive; couldn't lay down; sickness "generalized feeling of not being myself for the last two weeks"; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (problem breathing), DYSPHAGIA (problem swallowing), OROPHARYNGEAL DISCOMFORT (upward pressure on the base of throat and under sternum "like a fist"), LARYNGITIS (laryngitis-type state) and DYSPHONIA (severe hoarseness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COPD since an unknown date, Emphysema since an unknown date, Fibrosis since an unknown date, Bronchiectasis since an unknown date and Nodule (nodule on lung.) since an unknown date. Concurrent medical conditions included Allergy (allergies to multiple prescription medications).    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced DYSPNOEA (problem breathing), DYSPHAGIA (problem swallowing), OROPHARYNGEAL DISCOMFORT (upward pressure on the base of throat and under sternum "like a fist"), LARYNGITIS (laryngitis-type state), DYSPHONIA (severe hoarseness), THROAT IRRITATION (throat real sensitive), ORTHOPNOEA (couldn't lay down) and ILLNESS (sickness "generalized feeling of not being myself for the last two weeks"). At the time of the report, DYSPNOEA (problem breathing), DYSPHAGIA (problem swallowing), OROPHARYNGEAL DISCOMFORT (upward pressure on the base of throat and under sternum "like a fist"), LARYNGITIS (laryngitis-type state), DYSPHONIA (severe hoarseness), THROAT IRRITATION (throat real sensitive), ORTHOPNOEA (couldn't lay down) and ILLNESS (sickness "generalized feeling of not being myself for the last two weeks") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort, Orthopnoea, Throat irritation
Clinical narrative: problem breathing; problem swallowing; upward pressure on the base of throat and under sternum "like a fist"; laryngitis-type state; severe hoarseness; throat real sensitive; couldn't lay down; sickness "generalized feeling of not being myself for the last two weeks"; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (problem breathing), DYSPHAGIA (problem swallowing), OROPHARYNGEAL DISCOMFORT (upward pressure on the base of throat and under sternum "like a fist"), LARYNGITIS (laryngitis-type state) and DYSPHONIA (severe hoarseness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COPD since an unknown date, Emphysema since an unknown date, Fibrosis since an unknown date, Bronchiectasis since an unknown date and Nodule (nodule on lung.) since an unknown date. Concurrent medical conditions included Allergy (allergies to multiple prescription medications).    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced DYSPNOEA (problem breathing), DYSPHAGIA (problem swallowing), OROPHARYNGEAL DISCOMFORT (upward pressure on the base of throat and under sternum "like a fist"), LARYNGITIS (laryngitis-type state), DYSPHONIA (severe hoarseness), THROAT IRRITATION (throat real sensitive), ORTHOPNOEA (couldn't lay down) and ILLNESS (sickness "generalized feeling of not being myself for the last two weeks"). At the time of the report, DYSPNOEA (problem breathing), DYSPHAGIA (problem swallowing), OROPHARYNGEAL DISCOMFORT (upward pressure on the base of throat and under sternum "like a fist"), LARYNGITIS (laryngitis-type state), DYSPHONIA (severe hoarseness), THROAT IRRITATION (throat real sensitive), ORTHOPNOEA (couldn't lay down) and ILLNESS (sickness "generalized feeling of not being myself for the last two weeks") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Fatigue, Malaise, Pain
Clinical narrative: tiredness; achiness; doesn't feel good; uncomfortable; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), PAIN (achiness), MALAISE (doesn't feel good) and ANXIETY (uncomfortable) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Arthritis. Concomitant products included CELECOXIB (CELEBREX) for Arthritis.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (tiredness), PAIN (achiness), MALAISE (doesn't feel good) and ANXIETY (uncomfortable). At the time of the report, FATIGUE (tiredness), PAIN (achiness), MALAISE (doesn't feel good) and ANXIETY (uncomfortable) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment information provided patient said feeling better and all her events resolved 4 weeks back   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Follow up received on 03-May-2021. Events outcome was updated.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal discomfort, Pruritus
Clinical narrative: my nose is sore; Both of my forearms now itch; This spontaneous case was reported by a consumer and describes the occurrence of NASAL DISCOMFORT (my nose is sore) and PRURITUS (Both of my forearms now itch) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced NASAL DISCOMFORT (my nose is sore) and PRURITUS (Both of my forearms now itch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH STOPPING CREAM) for Itching, at an unspecified dose and frequency. At the time of the report, NASAL DISCOMFORT (my nose is sore) and PRURITUS (Both of my forearms now itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included diphenhydramine cream. No Concomitant medications were provided
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site pain, Injection site rash, Scratch
Clinical narrative: hives-looking rash,little larger than it was initially; Scratches during sleep; rash around the injection site; injection site was sore; headache; chills like crazy; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives-looking rash,little larger than it was initially), SCRATCH (Scratches during sleep), INJECTION SITE RASH (rash around the injection site), INJECTION SITE PAIN (injection site was sore) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and MONTELUKAST SODIUM (SINGULAIR) for Allergy NOS, AMLODIPINE and OLMESARTAN for Blood pressure high, ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol, LEVOTHYROXINE for Thyroid activity decreased.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced INJECTION SITE PAIN (injection site was sore), HEADACHE (headache) and CHILLS (chills like crazy). On 01-Mar-2021, the patient experienced URTICARIA (hives-looking rash,little larger than it was initially), SCRATCH (Scratches during sleep) and INJECTION SITE RASH (rash around the injection site). The patient was treated with CORTISONE for Prophylaxis, at an unspecified dose and frequency and DIMETICONE, MENTHOL, PRAMOCAINE HYDROCHLORIDE (GOLD BOND ANTI-ITCH) for Prophylaxis, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives-looking rash,little larger than it was initially), SCRATCH (Scratches during sleep), INJECTION SITE RASH (rash around the injection site), INJECTION SITE PAIN (injection site was sore), HEADACHE (headache) and CHILLS (chills like crazy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included CORTISONE and GOLD BOND ANTI-ITCH
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives-looking rash,little larger than it was initially; Scratches during sleep; rash around the injection site; injection site was sore; headache; chills like crazy; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives-looking rash,little larger than it was initially), SCRATCH (Scratches during sleep), INJECTION SITE RASH (rash around the injection site), INJECTION SITE PAIN (injection site was sore) and HEADACHE (headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and MONTELUKAST SODIUM (SINGULAIR) for Allergy NOS, AMLODIPINE and OLMESARTAN for Blood pressure high, ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol, LEVOTHYROXINE for Thyroid activity decreased.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced INJECTION SITE PAIN (injection site was sore), HEADACHE (headache) and CHILLS (chills like crazy). On 01-Mar-2021, the patient experienced URTICARIA (hives-looking rash,little larger than it was initially), SCRATCH (Scratches during sleep) and INJECTION SITE RASH (rash around the injection site). The patient was treated with CORTISONE for Prophylaxis, at an unspecified dose and frequency and DIMETICONE, MENTHOL, PRAMOCAINE HYDROCHLORIDE (GOLD BOND ANTI-ITCH) for Prophylaxis, at an unspecified dose and frequency. At the time of the report, URTICARIA (hives-looking rash,little larger than it was initially), SCRATCH (Scratches during sleep), INJECTION SITE RASH (rash around the injection site), INJECTION SITE PAIN (injection site was sore), HEADACHE (headache) and CHILLS (chills like crazy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included CORTISONE and GOLD BOND ANTI-ITCH
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: red rash on her arm that is hot to the touch and itchy; red rash on her arm that is hot to the touch and itchy; red rash on her arm that is hot to the touch and itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (red rash on her arm that is hot to the touch and itchy), VACCINATION SITE ERYTHEMA (red rash on her arm that is hot to the touch and itchy) and VACCINATION SITE PRURITUS (red rash on her arm that is hot to the touch and itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included No adverse event and No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE WARMTH (red rash on her arm that is hot to the touch and itchy), VACCINATION SITE ERYTHEMA (red rash on her arm that is hot to the touch and itchy) and VACCINATION SITE PRURITUS (red rash on her arm that is hot to the touch and itchy). At the time of the report, VACCINATION SITE WARMTH (red rash on her arm that is hot to the touch and itchy), VACCINATION SITE ERYTHEMA (red rash on her arm that is hot to the touch and itchy) and VACCINATION SITE PRURITUS (red rash on her arm that is hot to the touch and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided   Reporter did not allow further contact
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: high fever 103.9 C; terrible headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high fever 103.9 C) and HEADACHE (terrible headache) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced PYREXIA (high fever 103.9 C) and HEADACHE (terrible headache). At the time of the report, PYREXIA (high fever 103.9 C) and HEADACHE (terrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that he had fever of 103.9.  No concomitant medications were reported.  No treatment information was reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Skin swelling
Clinical narrative: Sore; Puffy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Sore) and SKIN SWELLING (Puffy) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced PAIN (Sore) and SKIN SWELLING (Puffy). At the time of the report, PAIN (Sore) and SKIN SWELLING (Puffy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Chills, Cough, Dyspnoea, Erythema
Clinical narrative: breathing difficult; Erythema; pyrexia; Chills; Bronchitis; Sweating; Redness on the arm and chest; Coughing,Cough Up Mucus; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing,Cough Up Mucus), BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest) and DYSPNOEA (breathing difficult) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Flu shot. Past adverse reactions to the above products included Bronchitis with Flu shot. Concurrent medical conditions included Chronic bronchitis, Asthma, Drug intolerance, Drug intolerance, Food allergy (Allergic to chocolate) and Egg allergy. Concomitant products included TRAMADOL for Back ache, VITAMIN D3 for Fatigue, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) and EPLERENONE for Hypertension, OMEPRAZOLE for Ulcer and GERD.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced COUGH (Coughing,Cough Up Mucus). On 25-Feb-2021, the patient experienced BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest) and CHILLS (Chills). 25-Feb-2021, the patient experienced PYREXIA (pyrexia) and HYPERHIDROSIS (sweat). On an unknown date, the patient experienced DYSPNOEA (breathing difficult). At the time of the report, COUGH (Coughing,Cough Up Mucus), BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest), DYSPNOEA (breathing difficult), PYREXIA (pyrexia), HYPERHIDROSIS (sweat) and CHILLS (Chills) outcome was unknown.            concomitant medication including Iron supplement 65mg  for 2 to 3 week for anaemia and benadryl  50 mg at night for itching is being taken by patient Treatment information was not provided.   This case was linked to MOD-2021-036981 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Patient medical history includes Intolerant of NSAIDS and ACE inhibitors, Flu shot were added On 05-May-2021: Initial additional included non-significant patient information . On 22-Jul-2021: TCR included no new significant information. On 05-Aug-2021: Added batch number for dose 1 , and added chocolate and food allergies, added concomitant medications, added few events
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Pyrexia, Vaccination site erythema
Clinical narrative: breathing difficult; Erythema; pyrexia; Chills; Bronchitis; Sweating; Redness on the arm and chest; Coughing,Cough Up Mucus; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Coughing,Cough Up Mucus), BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest) and DYSPNOEA (breathing difficult) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Product used for unknown indication: Flu shot. Past adverse reactions to the above products included Bronchitis with Flu shot. Concurrent medical conditions included Chronic bronchitis, Asthma, Drug intolerance, Drug intolerance, Food allergy (Allergic to chocolate) and Egg allergy. Concomitant products included TRAMADOL for Back ache, VITAMIN D3 for Fatigue, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) and EPLERENONE for Hypertension, OMEPRAZOLE for Ulcer and GERD.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced COUGH (Coughing,Cough Up Mucus). On 25-Feb-2021, the patient experienced BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest) and CHILLS (Chills). 25-Feb-2021, the patient experienced PYREXIA (pyrexia) and HYPERHIDROSIS (sweat). On an unknown date, the patient experienced DYSPNOEA (breathing difficult). At the time of the report, COUGH (Coughing,Cough Up Mucus), BRONCHITIS (Bronchitis), HYPERHIDROSIS (Sweating), ERYTHEMA (Redness on the arm and chest), DYSPNOEA (breathing difficult), PYREXIA (pyrexia), HYPERHIDROSIS (sweat) and CHILLS (Chills) outcome was unknown.            concomitant medication including Iron supplement 65mg  for 2 to 3 week for anaemia and benadryl  50 mg at night for itching is being taken by patient Treatment information was not provided.   This case was linked to MOD-2021-036981 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Mar-2021: Patient medical history includes Intolerant of NSAIDS and ACE inhibitors, Flu shot were added On 05-May-2021: Initial additional included non-significant patient information . On 22-Jul-2021: TCR included no new significant information. On 05-Aug-2021: Added batch number for dose 1 , and added chocolate and food allergies, added concomitant medications, added few events
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Eczema, Malaise
Clinical narrative: feeling sick; Eczema; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (Eczema) and MALAISE (feeling sick) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 001A21A) for COVID-19 vaccination.     The patient's past medical history included Bronchitis (she always has Bronchitis after Flu shot) since an unknown date. Previously administered products included for an unreported indication: RSV VACCINE. Concurrent medical conditions included Chronic bronchitis, Asthma, Drug allergy (Intolerant of NSAIDS), Drug allergy (Intolerant of ACE Inhibitors) and Food allergy (Chocolates and eggs). Concomitant products included IRON DEXTRAN (IRON [IRON DEXTRAN]) for Anemia, TRAMADOL for Back pain, VITAMIN D3 for Fatigue, OMEPRAZOLE for GERD, NEBIVOLOL HYDROCHLORIDE (BYSTOLIC) and EPLERENONE for Hypertension, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced ECZEMA (Eczema). On an unknown date, the patient experienced MALAISE (feeling sick). At the time of the report, ECZEMA (Eczema) had not resolved and MALAISE (feeling sick) outcome was unknown.            Treatment information was not provided.   This case was linked to MOD-2021-036980 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up information received on 05-AUG-2021 contains significant information including concomitants were captured, other relevant history captured, new event was captured and patient demographic details were captured.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 22-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced HEADACHE (Headache). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN MIGRAINE) for Migraine, at an unspecified dose and frequency; RIZATRIPTAN BENZOATE (MAXALT) for Prophylaxis, at an unspecified dose and frequency; PARACETAMOL (TYLENOL) for Prophylaxis, at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) for Prophylaxis, at an unspecified dose and frequency and TRAMADOL for Prophylaxis, at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Excedrin ES, Excedrin Migraine, Maxalt, Tylenol, Aleve, tramadol. No Concomitant medications were provided
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Musculoskeletal stiffness, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: thigh stiffness; mild fever; body aches; pain at the injected arm; stiffness of the of the legs, with a lot of pain; muscle spasms in her thighs; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MUSCULOSKELETAL STIFFNESS (thigh stiffness), PYREXIA (mild fever), MYALGIA (body aches), VACCINATION SITE PAIN (pain at the injected arm) and PAIN IN EXTREMITY (stiffness of the of the legs, with a lot of pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (body aches), VACCINATION SITE PAIN (pain at the injected arm) and MUSCLE SPASMS (muscle spasms in her thighs). 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (stiffness of the of the legs, with a lot of pain). On 26-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (thigh stiffness) and PYREXIA (mild fever). The patient was treated with IBUPROFEN for Prophylaxis, at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (thigh stiffness), PYREXIA (mild fever), MYALGIA (body aches), VACCINATION SITE PAIN (pain at the injected arm), PAIN IN EXTREMITY (stiffness of the of the legs, with a lot of pain) and MUSCLE SPASMS (muscle spasms in her thighs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Ibuprofen 200 No Concomitant medications were provided    Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: thigh stiffness; mild fever; body aches; pain at the injected arm; stiffness of the of the legs, with a lot of pain; muscle spasms in her thighs; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of MUSCULOSKELETAL STIFFNESS (thigh stiffness), PYREXIA (mild fever), MYALGIA (body aches), VACCINATION SITE PAIN (pain at the injected arm) and PAIN IN EXTREMITY (stiffness of the of the legs, with a lot of pain) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (body aches), VACCINATION SITE PAIN (pain at the injected arm) and MUSCLE SPASMS (muscle spasms in her thighs). 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (stiffness of the of the legs, with a lot of pain). On 26-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (thigh stiffness) and PYREXIA (mild fever). The patient was treated with IBUPROFEN for Prophylaxis, at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL STIFFNESS (thigh stiffness), PYREXIA (mild fever), MYALGIA (body aches), VACCINATION SITE PAIN (pain at the injected arm), PAIN IN EXTREMITY (stiffness of the of the legs, with a lot of pain) and MUSCLE SPASMS (muscle spasms in her thighs) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Ibuprofen 200 No Concomitant medications were provided    Reporter did not allow further contact
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Eye swelling, Headache, Pyrexia, Swelling
Clinical narrative: Swelling on the cheek bone; puffy face and eyes; headache; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling on the cheek bone), EYE SWELLING (puffy face and eyes), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling on the cheek bone), EYE SWELLING (puffy face and eyes), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills). At the time of the report, SWELLING (Swelling on the cheek bone), EYE SWELLING (puffy face and eyes), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided No Treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: event details added.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Flushing, Hyperhidrosis
Clinical narrative: stomach problems-upset with gas and more; felt flush- almost like a menopausal flush; terrible sweats; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach problems-upset with gas and more), FLUSHING (felt flush- almost like a menopausal flush) and HYPERHIDROSIS (terrible sweats) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. LOT 001A21A and 029K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included AMLODIPINE, RAMIPRIL, HYDROXYUREA and LEVOTHYROXINE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach problems-upset with gas and more), FLUSHING (felt flush- almost like a menopausal flush) and HYPERHIDROSIS (terrible sweats). At the time of the report, ABDOMINAL DISCOMFORT (stomach problems-upset with gas and more), FLUSHING (felt flush- almost like a menopausal flush) and HYPERHIDROSIS (terrible sweats) outcome was unknown. Not Provided          No Treatment information provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pyrexia
Clinical narrative: Extreme Fatigue; Chills; Fever - Temperature of 101.2F; Headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (Extreme Fatigue), CHILLS (Chills), PYREXIA (Fever - Temperature of 101.2F) and HEADACHE (Headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 027L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced FATIGUE (Extreme Fatigue), CHILLS (Chills), PYREXIA (Fever - Temperature of 101.2F) and HEADACHE (Headache). On 06-Mar-2021, FATIGUE (Extreme Fatigue), CHILLS (Chills), PYREXIA (Fever - Temperature of 101.2F) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided self treated with Tylenol   Reporter did not allow further contact
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain, Cough, Diarrhoea
Clinical narrative: Bad diarrhea; Abdominal pain; Dry cough; Sick stomach; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough), ABDOMINAL DISCOMFORT (Sick stomach), DIARRHOEA (Bad diarrhea) and ABDOMINAL PAIN (Abdominal pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced COUGH (Dry cough) and ABDOMINAL DISCOMFORT (Sick stomach). On 01-Mar-2021, the patient experienced DIARRHOEA (Bad diarrhea) and ABDOMINAL PAIN (Abdominal pain). At the time of the report, COUGH (Dry cough) and ABDOMINAL DISCOMFORT (Sick stomach) outcome was unknown and DIARRHOEA (Bad diarrhea) and ABDOMINAL PAIN (Abdominal pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Nausea
Clinical narrative: weak; dizzy; feeling real fatigued; fever; nausea; shaking really bad with chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), DIZZINESS (dizzy), NAUSEA (nausea), CHILLS (shaking really bad with chills) and FATIGUE (feeling real fatigued) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced NAUSEA (nausea), CHILLS (shaking really bad with chills) and PYREXIA (fever). On 07-Mar-2021, the patient experienced ASTHENIA (weak), DIZZINESS (dizzy) and FATIGUE (feeling real fatigued). At the time of the report, ASTHENIA (weak), DIZZINESS (dizzy), NAUSEA (nausea), CHILLS (shaking really bad with chills), FATIGUE (feeling real fatigued) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-1 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-1 test
Clinical narrative: weak; dizzy; feeling real fatigued; fever; nausea; shaking really bad with chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), DIZZINESS (dizzy), NAUSEA (nausea), CHILLS (shaking really bad with chills) and FATIGUE (feeling real fatigued) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced NAUSEA (nausea), CHILLS (shaking really bad with chills) and PYREXIA (fever). On 07-Mar-2021, the patient experienced ASTHENIA (weak), DIZZINESS (dizzy) and FATIGUE (feeling real fatigued). At the time of the report, ASTHENIA (weak), DIZZINESS (dizzy), NAUSEA (nausea), CHILLS (shaking really bad with chills), FATIGUE (feeling real fatigued) and PYREXIA (fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-1 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Appetite disorder, Asthenia, Back pain, Dizziness
Clinical narrative: dizzy; Sick; stiff; stomach sick; extreme weakness; back pain; lost weight; change in appetite; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick) and ASTHENIA (extreme weakness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick), ASTHENIA (extreme weakness), BACK PAIN (back pain), WEIGHT DECREASED (lost weight) and APPETITE DISORDER (change in appetite). At the time of the report, DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick), ASTHENIA (extreme weakness), BACK PAIN (back pain), WEIGHT DECREASED (lost weight) and APPETITE DISORDER (change in appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Musculoskeletal stiffness, Weight decreased
Clinical narrative: dizzy; Sick; stiff; stomach sick; extreme weakness; back pain; lost weight; change in appetite; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick) and ASTHENIA (extreme weakness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick), ASTHENIA (extreme weakness), BACK PAIN (back pain), WEIGHT DECREASED (lost weight) and APPETITE DISORDER (change in appetite). At the time of the report, DIZZINESS (dizzy), ILLNESS (Sick), MUSCULOSKELETAL STIFFNESS (stiff), ABDOMINAL DISCOMFORT (stomach sick), ASTHENIA (extreme weakness), BACK PAIN (back pain), WEIGHT DECREASED (lost weight) and APPETITE DISORDER (change in appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided    Reporter did not allow further contact